Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation

Heart

Volumn 94, Issue 3, 2008, Pages 311-315

  Sanchis, J ^a   Bosch, X ^b   Bodi V ^a   Bellera, N ^b   Nunez J ^a   Benito, B ^b   Ordonez J ^c   Consuegra, L ^a   Heras, M ^b   Llacer A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TROPONIN;

ADULT; ARTICLE; CLINICAL EVALUATION; CLINICAL STUDY; COHORT ANALYSIS; DEATH; DISEASE ASSOCIATION; EMERGENCY WARD; EXERCISE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REVASCULARIZATION; RISK FACTOR; ST SEGMENT; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL; THORAX PAIN;

BIOLOGICAL MARKERS; CHEST PAIN; EPIDEMIOLOGIC METHODS; EXERCISE TEST; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; TROPONIN;

EID: 39749116846     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.115626     Document Type: Article

References (30)

1. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease. The present and the future. J Am Coll Cardiol 2006;48:1-11.
2. Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST-elevation acute coronary syndromes. Simultaneous assessment of troponin I, C-reactive protein and B-type natriuretic peptide. Circulation 2002;105:1760-3.
3. Bodí V, Sanchis J, Llàcer A, et al. Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST elevation acute coronary syndromes. Am Heart J 2005;149:268-74.
4. Sanchis J, Bodí V, Llàcer A, et al. Risk stratification of patients with acute chest pain and normal troponin concentrations. Heart 2005;91:1013-18
5. Sanchis J, Bodí V, Núñez J, et al. New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score. J Am Coll Cardiol 2005;46:443-9.
6. Sanchis J, Bodí V, Núńez J, et al. A practical approach with outcome for the prognostic assessment of non-ST-segment elevation chest pain and normal troponin. Am J Cardiol 2007;99:797-801.
7. Sanchis J, Bodí V, Llácer A, et al. Emergency room risk stratification of patients with chest pain without ST-segment elevation. Rev Esp Cardiol 2003;56:955-62.
8. Sanchis J, Bodí V, Núńez J, et al. Usefulness of early exercise testing and clinical risk score for prognostic evaluation in chest pain units without preexisting evidence of myocardial ischemia. Am J Cardiol 2006;97:633-5.
9. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined. A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
10. Geleijnse ML, Elhendy A, Kasprzak JD, et al. Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram. Eur Heart J 2000;21:397-406.
11. DeFilippi ChR, Rosanio S, Tocchi M, et al. Randomized comparison of a strategy of predischarge coronary angiography versus exercise testing in low-risk patients in a chest pain-unit: in-hospital and long-term outcomes. J Am Coll Cardiol 2001;37:2042-9.
12. Amsterdam EA, Kirk JD, Diercks DB, et al. Immediate exercise testing to evaluate low-risk patients presenting to the emergency department with chest pain. J Am Coll Cardiol 2002;40:251-6.
13. De Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
14. Jernberg T, Stridsberg M, Venge P, et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-45.
15. Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST- elevation myocardial infarction. B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003;41:1262-72.
16. Heeschen Ch, Hamm ChW, Mitrovic V, et al. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110:3206- 12.
17. Galvani M, Ottani F, Oltrona L, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004;110:128-34.
18. Riezebos RK, Ronner E, de Boer RA, et al. Dynamics in N-terminal pro-brain natriuretic peptide concentration in patients with non-ST-elevation acute coronary syndrome. Am Heart J 2005;150: 1255-9.
19. Lund J, Qin QP, Hva T, et al. Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003;108:1924-6.
20. Heeschen Ch, Dimmeler S, Hamm ChW, et al. Pregnancy-associated plasma protein A levels in patients with acute coronary syndromes. Comparison with markers of systemic inflammation, platelet activation and myocardial necrosis. J Am Coll Cardiol 2005;45:229-37.
21. Laterza OF, Cameron SJ, Chappel D, et al. Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome. Clin Chim Acta 2004;348:163-69.
22. Qin Q-P, Laitinen P, Majamaa-Voltti K, et al. Release patterns of pregnancy-associated plasma protein A (PAPP-A) in patients with acute coronary syndromes. Scand Cardiovasc J 2002;36:358-61.
23. Quin Q-P, Kokkala S, Lund J, et al. Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin Chem 2006;52:398-404.
24. Brennan ML, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349:1595-604.
25. Lloyd-Jones DM, Camargo CA, Giugliano RP, et al. Effect of leukocytosis at initial examination on prognosis in patients with primary unstable angina. Am Heart J 2001;139:867-73.
26. Furman MI, Gore JM, Anderson FA, et al. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2004;147:42-8.
27. Cusack MR, Marber MS, Lambiase PD, et al. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 2002;39:1917-23.
28. Sanchis J, Bodí V, Llácer A, et al. Relationship of C-reactive protein levels with angiographic findings and markers of necrosis in non-ST-segment elevation acute coronary syndrome. Rev Esp Cardiol 2004;57:382-7.
29. Sanchis J, Bodí V, Núñez J, et al. Prognostic usefulness of white-blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain. Am J Cardiol 2006;98:885-9.
30. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med 2006;355:2615-17.